19-Feb-2026
Newsfile (Thu, 19-Feb 8:16 PM ET)
PRNewswire (Thu, 19-Feb 7:29 PM ET)
Globe Newswire (Thu, 19-Feb 4:00 PM ET)
Globe Newswire (Thu, 19-Feb 9:57 AM ET)
PRNewswire (Thu, 19-Feb 9:01 AM ET)
Globe Newswire (Wed, 18-Feb 5:17 PM ET)
PRNewswire (Wed, 18-Feb 9:01 AM ET)
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit
PRNewswire (Tue, 17-Feb 1:12 PM ET)
Globe Newswire (Tue, 17-Feb 11:22 AM ET)
Globe Newswire (Tue, 17-Feb 8:00 AM ET)
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Vistagen Therapeutics trades on the NASDAQ stock market under the symbol VTGN.
As of February 19, 2026, VTGN stock price climbed to $0.59 with 1,263,434 million shares trading.
VTGN has a beta of 0.62, meaning it tends to be less sensitive to market movements. VTGN has a correlation of 0.00 to the broad based SPY ETF.
VTGN has a market cap of $23.47 million. This is considered a Sub-Micro Cap stock.
Last quarter Vistagen Therapeutics reported $303,000 in Revenue and -$.45 earnings per share. This beat revenue expectation by $46,480 and missed earnings estimates by -$.06.
In the last 3 years, VTGN traded as high as $24.71 and as low as $.43.
The top ETF exchange traded funds that VTGN belongs to (by Net Assets): VTI, VXF, PSIL, IWC, DFAS.
VTGN has underperformed the market in the last year with a return of -79.2%, while the SPY ETF gained +12.9%. In the last 3 month period, VTGN fell short of the market, returning -86.8%, while SPY returned +3.6%. However, in the most recent 2 weeks VTGN has outperformed the stock market by returning +17.3%, while SPY returned +1.0%.
VTGN support price is $.49 and resistance is $.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VTGN shares will trade within this expected range on the day.
